Efficacy and safety of propofol administration with esTEC, a pharmacodynamic index.

Efficacy and safety of propofol administration with esTEC, a pharmacodynamic index. - Propofol administration with esTEC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033378

Enrollment

200

Registered

2023-03-31

Start date

2017-05-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients scheduled for an elective surgery requiring general anesthesia

Interventions

esTEC control group manual group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for elective surgery requiring general anesthesia

Exclusion criteria

Exclusion criteria: Patients with general anestheisia with nerve block and epidural anesthesia

Design outcomes

Primary

Measure	Time frame
average BIS value, the percentage of time with BIS between 35 and 55, the percentage of time with BIS >55,the percentage of time with BIS <35, burst suppression ratio, Blood pressure and pulse fluctuation,time to tracheal extubatuion, drugs consumption	—

Countries

Japan

Contacts

Public ContactYuka Matsuki

Faculty of Medical Sciences, University of Fukui Department of Anaesthesiology & Reanimatology

ymatsuki@u-fukui.ac.jp0776618391

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026